| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ijin Joo | Q88093830 |
| Jae Hyun Kim | Q91599636 | ||
| Jeong Min Lee | Q56754340 | ||
| P2860 | cites work | Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues | Q26770020 |
| JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan | Q26797521 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study | Q33403106 | ||
| The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging | Q84230646 | ||
| Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? | Q86935141 | ||
| Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI | Q87228955 | ||
| EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma | Q88301343 | ||
| Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging | Q89338368 | ||
| Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS) | Q90994423 | ||
| Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation | Q33589095 | ||
| Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases | Q33768669 | ||
| Diagnostic Value of Gd-EOB-DTPA-MRI for Hepatocellular Adenoma: A Meta-Analysis | Q33776767 | ||
| Intrahepatic peripheral cholangiocarcinoma: CT evaluation | Q33912789 | ||
| Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. | Q34136980 | ||
| Hepatic adenomas: imaging and pathologic findings | Q34307927 | ||
| Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors | Q34398255 | ||
| Hepatic arterioportal shunts: dynamic CT and MR features | Q34580237 | ||
| Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. | Q34585928 | ||
| Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia | Q34603806 | ||
| CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects | Q34681076 | ||
| CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features | Q34682228 | ||
| Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation | Q34732031 | ||
| Early hepatocellular carcinoma as an entity with a high rate of surgical cure | Q34754443 | ||
| Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. | Q34975197 | ||
| Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography | Q35093299 | ||
| Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations | Q35186339 | ||
| Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis | Q35632208 | ||
| 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation | Q35895277 | ||
| Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography | Q35936570 | ||
| Histopathology of liver cancers | Q36066442 | ||
| Hepatocellular carcinoma: epidemiology, risk factors, and screening | Q36140282 | ||
| Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. | Q36325824 | ||
| Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging | Q36333396 | ||
| Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation. | Q36365466 | ||
| Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes | Q36512761 | ||
| MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma | Q36757993 | ||
| Epidemiology of hepatocellular carcinoma: consider the population | Q36930514 | ||
| MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies | Q37145592 | ||
| Hepatic Angiomyolipoma Versus Hepatocellular Carcinoma in the Noncirrhotic Liver on Gadoxetic Acid-Enhanced MRI: A Diagnostic Challenge. | Q50892267 | ||
| Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. | Q51000636 | ||
| Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. | Q51394139 | ||
| Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver | Q51674471 | ||
| Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. | Q39065107 | ||
| Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree | Q39922989 | ||
| Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study | Q39973128 | ||
| Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis | Q39974780 | ||
| Angiomyolipoma of the liver: a collective review | Q40760491 | ||
| Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update | Q41962614 | ||
| Focal nodular hyperplasia: Central scar enhancement pattern using gadoxetate disodium | Q42949683 | ||
| Subtype classification of hepatocellular adenoma | Q43112827 | ||
| "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor | Q43236786 | ||
| Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. | Q43474554 | ||
| Focal eosinophilic infiltration in the liver: radiologic findings and clinical course. | Q44420913 | ||
| Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma | Q44663942 | ||
| New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma | Q45013873 | ||
| 2017 Version of LI-RADS for CT and MR Imaging: An Update. | Q46058029 | ||
| Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. | Q46379419 | ||
| Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation | Q47584144 | ||
| Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. | Q47730953 | ||
| cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. | Q48513742 | ||
| A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. | Q48718249 | ||
| Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis | Q48955216 | ||
| CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation | Q49168743 | ||
| Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents | Q49990648 | ||
| Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. | Q51765607 | ||
| Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. | Q51798621 | ||
| Clinicopathological study of scirrhous hepatocellular carcinoma. | Q52009746 | ||
| Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging. | Q52927877 | ||
| Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings. | Q52982866 | ||
| Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T. | Q53091405 | ||
| Fading hepatic hemangiomas on multiphasic CT. | Q53187411 | ||
| Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. | Q53217460 | ||
| Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. | Q53367271 | ||
| Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. | Q53370566 | ||
| MRI features of hepatocellular carcinoma expressing progenitor cell markers. | Q53398114 | ||
| Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. | Q53445917 | ||
| MR findings of focal eosinophilic liver disease using gadoxetic acid | Q53460131 | ||
| Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. | Q53558541 | ||
| Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. | Q53619861 | ||
| Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges | Q57116208 | ||
| Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma | Q57216380 | ||
| EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma | Q57756593 | ||
| Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC | Q57782566 | ||
| Hepatocellular carcinoma | Q58020832 | ||
| Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI | Q58021245 | ||
| Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases | Q59150373 | ||
| Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent | Q59510517 | ||
| Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings | Q61737177 | ||
| Fibrolamellar hepatocellular carcinoma | Q70107458 | ||
| Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors | Q70469087 | ||
| Hepatocellular carcinoma with sarcomatous change: characteristic findings of two-phased incremental CT | Q71167206 | ||
| Hepatic adenoma: MR findings in 51 pathologically proved lesions | Q72837041 | ||
| Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features | Q72855415 | ||
| Hepatocellular carcinoma presenting as intrabile duct tumor growth. A clinicopathologic study of 24 cases | Q72928961 | ||
| Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features | Q73044883 | ||
| Early hepatocellular carcinoma presenting with biliary ductal invasion--a case report | Q73628700 | ||
| Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases | Q73797012 | ||
| Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study | Q76402954 | ||
| The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology | Q77953205 | ||
| Intrahepatic cholangiocarcinoma with marked hypervascularity | Q77954183 | ||
| Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study | Q79835026 | ||
| Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma | Q79914640 | ||
| Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma | Q80337206 | ||
| Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma | Q81646119 | ||
| Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification | Q81758885 | ||
| Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis | Q82299264 | ||
| Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma | Q82779836 | ||
| Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging | Q82900790 | ||
| Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience | Q84194027 | ||
| Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. | Q37157400 | ||
| HCC diagnosis with liver-specific MRI--close to histopathology | Q37527606 | ||
| Diffusion-weighted MR imaging of the liver. | Q37661956 | ||
| Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. | Q37766703 | ||
| Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method | Q37847767 | ||
| Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings | Q37862905 | ||
| Genetics and imaging of hepatocellular adenomas: 2011 update | Q37945554 | ||
| High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis | Q37965042 | ||
| Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis | Q37979150 | ||
| Congenital heart disease and the liver | Q37989892 | ||
| Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. | Q38026533 | ||
| Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. | Q38034517 | ||
| Imaging-based diagnostic systems for hepatocellular carcinoma | Q38116045 | ||
| Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. | Q38123870 | ||
| Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging | Q38250907 | ||
| Hepatobiliary agents and their role in LI-RADS. | Q38257321 | ||
| Non-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic livers | Q38265712 | ||
| The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis | Q38299642 | ||
| Radiological features of hepatocellular carcinoma | Q38371627 | ||
| Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging | Q38489567 | ||
| MRI findings of focal eosinophilic liver diseases | Q38514396 | ||
| Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging | Q38587512 | ||
| Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. | Q38602423 | ||
| Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. | Q38608806 | ||
| Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas | Q38617247 | ||
| Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014. | Q38647654 | ||
| Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI. | Q38684422 | ||
| LI-RADS(®) algorithm: CT and MRI. | Q38684954 | ||
| Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging | Q38701219 | ||
| Hepatocellular Carcinoma: Histologic Subtypes | Q38720948 | ||
| Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma | Q38727935 | ||
| Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases | Q38729456 | ||
| Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma | Q38765247 | ||
| Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging | Q38807996 | ||
| Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review | Q38998297 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P1104 | number of pages | 23 | |
| P304 | page(s) | 1019-1041 | |
| P577 | publication date | 2019-07-01 | |
| P1433 | published in | Korean journal of radiology : official journal of the Korean Radiological Society | Q26842124 |
| P1476 | title | Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging | |
| P478 | volume | 20 |
| Q89824104 | Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute |
| Q98564465 | Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography |
Search more.